ondansetron has been researched along with Vertigo in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two young women with chronic nausea and vertigo caused by multiple sclerosis responded to the introduction and maintenance of the 5HT3 receptor antagonist, ondansetron." | 7.70 | Ondansetron in multiple sclerosis. ( Macleod, AD, 2000) |
| "Two young women with chronic nausea and vertigo caused by multiple sclerosis responded to the introduction and maintenance of the 5HT3 receptor antagonist, ondansetron." | 3.70 | Ondansetron in multiple sclerosis. ( Macleod, AD, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rice, GP | 1 |
| Ebers, GC | 1 |
| Macleod, AD | 1 |
2 other studies available for ondansetron and Vertigo
| Article | Year |
|---|---|
Ondansetron for intractable vertigo complicating acute brainstem disorders.
Topics: Acute Disease; Adult; Brain Diseases; Brain Stem; Humans; Middle Aged; Multiple Sclerosis; Ondansetr | 1995 |
Ondansetron in multiple sclerosis.
Topics: Adult; Female; Humans; Multiple Sclerosis; Nausea; Ondansetron; Palliative Care; Serotonin Antagonis | 2000 |